Movatterモバイル変換


[0]ホーム

URL:


Lecturio medical combi logo
Lecturio medical logo

Interstitial Lung Diseases

Interstitial lung diseases are a heterogeneous group of disorders characterized by theinflammationInflammationInflammation is a complex set of responses to infection and injury involving leukocytes as the principal cellular mediators in the body's defense against pathogenic organisms. Inflammation is also seen as a response to tissue injury in the process of wound healing. The 5 cardinal signs of inflammation are pain, heat, redness, swelling, and loss of function.Inflammation andfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans of lung parenchyma, especially the pulmonaryconnective tissueConnective tissueConnective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix.Connective Tissue: Histology in the alveolar walls. It may beidiopathicIdiopathicDermatomyositis (e.g.,idiopathicIdiopathicDermatomyositis pulmonaryfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans) or secondary toconnective tissueConnective tissueConnective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix.Connective Tissue: Histology diseases, medications, malignancies, occupational exposure, or allergens. Interstitial lung diseases commonly present with progressive exertionaldyspneaDyspneaDyspnea is the subjective sensation of breathing discomfort. Dyspnea is a normal manifestation of heavy physical or psychological exertion, but also may be caused by underlying conditions (both pulmonary and extrapulmonary).Dyspnea anddry coughDry CoughStrongyloidiasis.Pulmonary function testingPulmonary Function TestingPulmonary Function Tests shows a restrictive lung disease pattern. Lung high-resolution computed tomography andbiopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma usually establish the diagnosis. Treatment includessteroidsSteroidsA group of polycyclic compounds closely related biochemically to terpenes. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (sterols), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus.Benign Liver Tumors and immunosuppressives.

Last updated: May 17, 2024

Editorial responsibility:Stanley Oiseth, Lindsay Jones, Evelin Maza

Overview

Definition

  • Interstitial lung disease (ILD) comprises a heterogeneous group of disorders that cause varying degrees ofinflammationInflammationInflammation is a complex set of responses to infection and injury involving leukocytes as the principal cellular mediators in the body’s defense against pathogenic organisms. Inflammation is also seen as a response to tissue injury in the process of wound healing. The 5 cardinal signs of inflammation are pain, heat, redness, swelling, and loss of function.Inflammation andfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans of the lung interstitium, the space between the capillaryendotheliumEndotheliumA layer of epithelium that lines the heart, blood vessels (vascular endothelium), lymph vessels (lymphatic endothelium), and the serous cavities of the body.Arteries: Histology and the alveolarepitheliumEpitheliumThe epithelium is a complex of specialized cellular organizations arranged into sheets and lining cavities and covering the surfaces of the body. The cells exhibit polarity, having an apical and a basal pole. Structures important for the epithelial integrity and function involve the basement membrane, the semipermeable sheet on which the cells rest, and interdigitations, as well as cellular junctions.Surface Epithelium: Histology.
  • Clinically, affectedpatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship will show restrictive lung disease by pulmonary function studies.

Epidemiology

IdiopathicIdiopathicDermatomyositis pulmonaryfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans,sarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis, and ILD associated withconnective tissueConnective tissueConnective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix.Connective Tissue: Histology diseases are the most common types of ILD.

Classification

It is useful to categorize ILDs into those with and without a known cause.

Table: Types of interstitial lung disease
Cause unknownCause known
IdiopathicIdiopathicDermatomyositis interstitial pneumonias (IIP):
  • IdiopathicIdiopathicDermatomyositis pulmonaryfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans (IPF)
  • Nonspecific interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia (NSIP)
  • Cryptogenic organizing pneumoniaCryptogenic organizing pneumoniaAn interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a ‘pneumonia-like’ illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.Bronchiolitis Obliterans (COP)
  • Acute interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia (AIP)
Smoking-related ILD:
  • Respiratory bronchiolitis-associated interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia (RB-AIP)
  • Desquamative interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia (DIP)
Other:
Systemic diseases
  • Connective tissueConnective tissueConnective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix.Connective Tissue: Histology diseases (CTDCTDDisorders of Fatty Acid Metabolism)
    • RheumatoidarthritisArthritisAcute or chronic inflammation of joints.Osteoarthritis (RA)
    • Systemic lupus erythematosusSystemic lupus erythematosusSystemic lupus erythematosus (SLE) is a chronic autoimmune, inflammatory condition that causes immune-complex deposition in organs, resulting in systemic manifestations. Women, particularly those of African American descent, are more commonly affected.Systemic Lupus Erythematosus
    • SystemicsclerosisSclerosisA pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.Wilms Tumor
    • Sjogren’s disease
    • DermatomyositisDermatomyositisA subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms.Paraneoplastic Syndromes/polymyositisPolymyositisPolymyositis (PM) is an autoimmune inflammatory myopathy caused by T cell-mediated muscle injury. The etiology of PM is unclear, but there are several genetic and environmental associations. Polymyositis is most common in middle-aged women and rarely affects children.Polymyositis
  • Granulomatous diseaseGranulomatous diseaseA defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the cybb gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by cyba, ncf1, ncf2, or ncf4 gene mutations, the condition is inherited in an autosomal recessive pattern.Common Variable Immunodeficiency (CVID)
    • Granulomatosis with polyangiitisGranulomatosis with PolyangiitisA multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (vasculitis) leading to damage in any number of organs. The common features include granulomatous inflammation of the respiratory tract and kidneys. Most patients have measurable autoantibodies (antineutrophil cytoplasmic antibodies) against myeloblastin.Granulomatosis with Polyangiitis
    • Churg-Strauss disease
    • Pulmonary Langerhans cell histiocytosis (PLCH)
    • SarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis
    • HypersensitivitypneumonitisPneumonitisHuman Herpesvirus 6 and 7 (HP)
Exposure-related
  • Occupational
    • AsbestosisAsbestosisA form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.Pneumoconiosis
    • SilicosisSilicosisA form of pneumoconiosis resulting from inhalation of dust containing crystalline form of silicon dioxide, usually in the form of quartz. Amorphous silica is relatively nontoxic.Pneumoconiosis
    • Gases/fumes
  • Pharmacologic:
    RadiationRadiationEmission or propagation of acoustic waves (sound), electromagnetic energy waves (such as light; radio waves; gamma rays; or x-rays), or a stream of subatomic particles (such as electrons; neutrons; protons; or alpha particles).Osteosarcoma,methotrexateMethotrexateAn antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate dehydrogenase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.Antimetabolite Chemotherapy,azathioprineAzathioprineAn immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the fourth annual report on carcinogens, this substance has been listed as a known carcinogen.Immunosuppressants,rituximabRituximabA murine-derived monoclonal antibody and antineoplastic agent that binds specifically to the cd20 antigen and is used in the treatment of leukemia; lymphoma and rheumatoid arthritis.Immunosuppressants, tumor-necrosis factor blockers,amiodaroneAmiodaroneAn antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting potassium channels and voltage-gated sodium channels. There is a resulting decrease in heart rate and in vascular resistance.Pulmonary Fibrosis, nitrofurantoin, chemotherapeutics

Diagnosis

History

Age
  • IPF is rare inpatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship < 50 years
  • SarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis, CTD-associated ILD, andLAMLAMTuberous Sclerosis are common between the ages of 20 and 40 years
SexSexThe totality of characteristics of reproductive structure, functions, phenotype, and genotype, differentiating the male from the female organism.Gender Dysphoria
  • LAMLAMTuberous Sclerosis and CTD-associated ILD, except rheumatoid arthritis-associated ILD, are frequently found in women
  • IPF and occupational ILDs are more common in men
Clinical presentation
  • Acute onset (days to weeks): eosinophilicpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia, acute interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia, hypersensitivitypneumonitisPneumonitisHuman Herpesvirus 6 and 7,granulomatosis with polyangiitisGranulomatosis with PolyangiitisA multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (vasculitis) leading to damage in any number of organs. The common features include granulomatous inflammation of the respiratory tract and kidneys. Most patients have measurable autoantibodies (antineutrophil cytoplasmic antibodies) against myeloblastin.Granulomatosis with Polyangiitis, acute exacerbation of IPF
  • Subacute onset (weeks to months) and especially chronic onset (months to years): most other ILDs, especially IPF
Symptoms
  • Progressive exertionaldyspneaDyspneaDyspnea is the subjective sensation of breathing discomfort. Dyspnea is a normal manifestation of heavy physical or psychological exertion, but also may be caused by underlying conditions (both pulmonary and extrapulmonary).Dyspnea (most common)
  • Dry coughDry CoughStrongyloidiasis (very common)
  • FatigueFatigueThe state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.Fibromyalgia (common)
  • ChestpainPainAn unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons.Pain: Types and Pathways (uncommon; suggestssarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis)
  • HemoptysisHemoptysisHemoptysis is defined as the expectoration of blood originating in the lower respiratory tract. Hemoptysis is a consequence of another disease process and can be classified as either life threatening or non-life threatening. Hemoptysis can result in significant morbidity and mortality due to both drowning (reduced gas exchange as the lungs fill with blood) and hemorrhagic shock.Hemoptysis (rare; suggestsvasculitisVasculitisInflammation of any one of the blood vessels, including the arteries; veins; and rest of the vasculature system in the body.Systemic Lupus Erythematosus,LAMLAMTuberous Sclerosis)
Past medical historyPast Medical HistoryAdult Health Maintenance
  • CTDCTDDisorders of Fatty Acid Metabolism or symptoms ofCTDCTDDisorders of Fatty Acid Metabolism such as Raynaud’s phenomena
  • MalignancyMalignancyHemothorax, which may indicate dermatomyositis-associated ILD
  • AsthmaAsthmaAsthma is a chronic inflammatory respiratory condition characterized by bronchial hyperresponsiveness and airflow obstruction. The disease is believed to result from the complex interaction of host and environmental factors that increase disease predisposition, with inflammation causing symptoms and structural changes. Patients typically present with wheezing, cough, and dyspnea.Asthma may suggest eosinophilicgranulomatosis with polyangiitisGranulomatosis with PolyangiitisA multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (vasculitis) leading to damage in any number of organs. The common features include granulomatous inflammation of the respiratory tract and kidneys. Most patients have measurable autoantibodies (antineutrophil cytoplasmic antibodies) against myeloblastin.Granulomatosis with Polyangiitis (also known as Churg-Strauss)
Drug historyMethotrexateMethotrexateAn antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate dehydrogenase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.Antimetabolite Chemotherapy,azathioprineAzathioprineAn immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the fourth annual report on carcinogens, this substance has been listed as a known carcinogen.Immunosuppressants,rituximabRituximabA murine-derived monoclonal antibody and antineoplastic agent that binds specifically to the cd20 antigen and is used in the treatment of leukemia; lymphoma and rheumatoid arthritis.Immunosuppressants, tumor-necrosis factor blockers,amiodaroneAmiodaroneAn antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting potassium channels and voltage-gated sodium channels. There is a resulting decrease in heart rate and in vascular resistance.Pulmonary Fibrosis, nitrofurantoin, chemotherapeutics
Family historyFamily HistoryAdult Health MaintenanceHaving a close relative with IIP is a strong risk factor for ILD, especially IPF.
Social historySocial HistoryAdult Health Maintenance
  • Smoking history is present in almost all cases of DIP and the majority of IPFpatientsPatientsIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.Clinician–Patient Relationship.
  • Exposure history such as to asbestos or birds (HP)

Physical examination

  • End-inspiratory fine crackles in lungbasesBasesUsually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines.Acid-Base Balance (common finding, especially in IPF)
  • WheezingWheezingWheezing is an abnormal breath sound characterized by a whistling noise that can be relatively high-pitched and shrill (more common) or coarse. Wheezing is produced by the movement of air through narrowed or compressed small (intrathoracic) airways.Wheezing is uncommon (may be found in HP, Churg-Strauss disease,sarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis)
  • Severe disease findings:cyanosisCyanosisA bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.Pulmonary Examination, digitalclubbingClubbingCardiovascular Examination,cor pulmonaleCor PulmonaleCor pulmonale is right ventricular (RV) dysfunction caused by lung disease that results in pulmonary artery hypertension. The most common cause of cor pulmonale is chronic obstructive pulmonary disease. Dyspnea is the usual presenting symptom.Cor Pulmonale

Laboratory studies

Autoantibody detection may help with the diagnosis of some CTDs.

Pulmonary function testingPulmonary Function TestingPulmonary Function Tests

  • The diffusing capacity forcarbon monoxideCarbon monoxideCarbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death.Carbon Monoxide Poisoning (DLCODLCOPulmonary Function Tests) shows reduction.
  • Most show a restrictive pattern.

Imaging

  • ChestX-rayX-rayPenetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard x-rays are the higher energy, shorter wavelength x-rays. Soft x-rays or grenz rays are less energetic and longer in wavelength. The short wavelength end of the x-ray spectrum overlaps the gamma rays wavelength range. The distinction between gamma rays and x-rays is based on their radiation source.Pulmonary Function Tests may be suggestive of a type of ILD:
    • Peripheral reticular pattern in lower lung zones and smallcysticCysticFibrocystic Change spaces suggests IPF.
    • Central nodular pattern in mid-to-upper lung zones and hilarlymphLymphThe interstitial fluid that is in the lymphatic system.Secondary Lymphatic Organs node enlargement suggestssarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis.
  • Chest computed tomographyChest Computed TomographyHemothorax (CT):
    • Standard initial test
    • May confirm the diagnosis of IPF in the right setting and obviate the need forlung biopsyLung BiopsyAntineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
    • Better defines disease extent and features (e.g., honeycombing)
    • Helps excludecomorbiditiesComorbiditiesThe presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.St. Louis Encephalitis Virus (e.g.,pneumothoraxPneumothoraxA pneumothorax is a life-threatening condition in which air collects in the pleural space, causing partial or full collapse of the lung. A pneumothorax can be traumatic or spontaneous. Patients present with a sudden onset of sharp chest pain, dyspnea, and diminished breath sounds on exam.Pneumothorax) or differential diagnosis (e.g.,malignancyMalignancyHemothorax)
    • Helps determine the best location forbiopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma

Lung biopsyLung BiopsyAntineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

  • Establishes the diagnosis
  • Performed via fiberopticbronchoscopyBronchoscopyEndoscopic examination, therapy or surgery of the bronchi.Laryngomalacia and Tracheomalacia or surgery
  • BiopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma is not needed if:
    • High-resolution CTHigh-resolution CTImaging of the Lungs and Pleura (HRCTHRCTPulmonary Function Tests) shows classic usual interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia and the patient has no systemic diseases suggestive of an another disorder.
    • Patient has minimal signs or symptoms and a stable/nonprogressive disease.
  • Indicated in cases ofcomorbiditiesComorbiditiesThe presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.St. Louis Encephalitis Virus or rapidly progressive symptoms

Individual Forms

IdiopathicIdiopathicDermatomyositis pulmonaryfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans

  • Most common ILD of unknown cause
  • Commonly diagnosed in 5th or 6th decade
  • Affects men more than women
  • Frequently associated with smoking
  • 35-year survival rate is 50%.
  • May be associated with acute exacerbations
  • LungHRCTHRCTPulmonary Function Tests shows a pattern of UIP: subpleural reticular pattern with posterior-basal predominance with more advanced fibrotic features such as honeycombing and tractionbronchiectasisBronchiectasisBronchiectasis is a chronic disease of the airways that results from permanent bronchial distortion. This results from a continuous cycle of inflammation, bronchial damage and dilation, impaired clearance of secretions, and recurrent infections.Bronchiectasis.
  • Histopathology shows a pattern of UIP:subpleural reticulationSubpleural reticulationPulmonary Fibrosis, honeycombing,fibroblastsFibroblastsConnective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.Sarcoidosis, skipped lesions with preserved architecture (temporal and spatial heterogeneity).
  • Treatment:physical therapyPhysical TherapyBecker Muscular Dystrophy andsupplemental oxygenSupplemental OxygenRespiratory Failure, antifibrotic therapy (pirfenidonePirfenidonePulmonary Fibrosis), andlung transplantationLung transplantationThe transference of either one or both of the lungs from one human or animal to another.Organ Transplantation if patient meets criteria
Typical high-resolution computed tomography (hrct) pattern of usual interstitial pneumonia

Typical HRCT pattern of UIP. The image shows subpleural and basal predominance of reticular opacities associated with traction bronchiectasis and honeycomb change (clustered cystic airspaces with well-defined thick walls and diameter of 0.3–1.0 cm)

Image: “(HRCT) pattern” by Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK. License:CC BY 4.0
Idiopathic pulmonary fibrosis

Posterior-anterior chest radiograph of a 67-year-old man with progressive dyspnea revealing bilateral reticular infiltrates with lower lobe predominance

Image: “PA chest radiograph of a 67-year old man” by Department of Medicine, Division of Pulmonary, Allergy and Critical Care, Duke University Medical Center, Durham, North Carolina 27710, USA. License:CC BY 2.0
Photomicrograph of biopsy from a 63-year-old man with a multi-disciplinary diagnosis of idiopathic pulmonary fibrosis

Photomicrograph of biopsy from a 63-year-old man with a multi-disciplinary diagnosis of IPF. The patient shows the typical histopathological features of usual interstitial pneumonia characterized by spatial heterogeneity with areas of subpleural and paraseptal fibrosis and honeycombing changes (cystic airspaces lined by bronchiolar epithelium) alternating with areas of relatively spared lung parenchyma, temporal heterogeneity with admixed areas of active fibrosis with fibroblast foci, extracellular matrix deposition (mainly collagen), and relatively mild or absence of inflammatory cell infiltrate together with regions of histologically normal lung tissue.

Image: “Photomicrograph of biopsy from a 63-year-old man with a multi-disciplinary diagnosis of idiopathic pulmonary fibrosis” by Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK. License:CC BY 4.0

Non-specific interstitialpneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia

  • May beidiopathicIdiopathicDermatomyositis or commonly associated with CTDs
  • Commonly diagnosed in non-smoking women in their 5th decade
  • 5-year survival rate is 80%.
  • LungHRCTHRCTPulmonary Function Tests shows diffuse and symmetric subpleural ground-glass and reticular opacities; tractionbronchiectasisBronchiectasisBronchiectasis is a chronic disease of the airways that results from permanent bronchial distortion. This results from a continuous cycle of inflammation, bronchial damage and dilation, impaired clearance of secretions, and recurrent infections.Bronchiectasis may be seen; honeycombing and peribronchial thickening is uncommon.
  • Histopathology shows uniform interstitialinflammationInflammationInflammation is a complex set of responses to infection and injury involving leukocytes as the principal cellular mediators in the body’s defense against pathogenic organisms. Inflammation is also seen as a response to tissue injury in the process of wound healing. The 5 cardinal signs of inflammation are pain, heat, redness, swelling, and loss of function.Inflammation andfibrosisFibrosisAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.Bronchiolitis Obliterans without honeycombing.
  • Treatment:physical therapyPhysical TherapyBecker Muscular Dystrophy,supplemental oxygenSupplemental OxygenRespiratory Failure,steroidsSteroidsA group of polycyclic compounds closely related biochemically to terpenes. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (sterols), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus.Benign Liver Tumors, immunosuppressive therapy, andlung transplantationLung transplantationThe transference of either one or both of the lungs from one human or animal to another.Organ Transplantation if patient meets criteria
Drug induced lung disease

Drug-induced lung disease with am NSIP pattern. The patient has undergone chemotherapy for bladder cancer. Chest CT at the level of the right pulmonary artery at lung window. Diffuse bilateral peripheral reticular pattern, ground glass, and some consolidation.

Image: “Drug-induced lung disease” by Department of Diagnostic and Interventional Radiology, Marien Hospital, Academic Teaching Hospital, Rochusstr. 2, D- 40479, Düsseldorf, Germany. License:CC BY 4.0
Non specific interstitial pneumonia

Non-specific interstitial pneumonia. A mesh-like fibrosis of the alveolar septa is seen. Fibroblastic foci are not found. Aggregates of lymphocytes are sometimes found (HE, original magnification 40x).

Image: “Non specific interstitial pneumonia” by Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany. License:CC BY 2.0

Cryptogenic organizing pneumoniaCryptogenic organizing pneumoniaAn interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a ‘pneumonia-like’ illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.Bronchiolitis Obliterans

  • May beidiopathicIdiopathicDermatomyositis or secondary topolymyositisPolymyositisPolymyositis (PM) is an autoimmune inflammatory myopathy caused by T cell-mediated muscle injury. The etiology of PM is unclear, but there are several genetic and environmental associations. Polymyositis is most common in middle-aged women and rarely affects children.Polymyositis, medications, ormalignancyMalignancyHemothorax
  • Commonly diagnosed in 6th or 7th decade
  • LungHRCTHRCTPulmonary Function Tests shows migratory, patchy, subpleural consolidations and ground-glass opacities with or without a rim of subpleural sparing known as thehalo signHalo signAspergillus/Aspergillosis (characteristic).
  • Treatment:steroidsSteroidsA group of polycyclic compounds closely related biochemically to terpenes. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (sterols), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus.Benign Liver Tumors and immunosuppressives
Bronchiolitis obliterans organizing pneumonia

A 59-year-old woman with a history of left breast cancer and radical mastectomy. The patient was diagnosed with radiotherapy- induced cryptogenic organizing pneumonia (formerly known as bronchiolitis obliterans organizing pneumonia). Computed tomography shows patchy areas in the left lung and in the middle lobe of the right lung.

Image: “Bronchiolitis obliterans organizing pneumonia” by Dept of Pulmonary Diseases, Sint Franciscus Gasthuis, Rotterdam, The Netherlands. License:CC BY 2.0
Cryptogenic organizing pneumonia

Cryptogenic organizing pneumonia: In alveolar ducts and bronchioles, buds of granulation tissue are detected (HE, original magnification 100x).

Image: “Cryptogenic organizing pneumonia” by Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45147, Germany. License:CC BY 2.0

Smoking-related ILD

  • Occurs in heavy smokers in the 5th or 6th decade
  • Honeycombing is typically absent
  • BiopsyBiopsyRemoval and pathologic examination of specimens from the living body.Ewing Sarcoma confirms diagnosis
  • Treatment includes smoking cessation and immunosuppressive therapy

Connective tissueConnective tissueConnective tissues originate from embryonic mesenchyme and are present throughout the body except inside the brain and spinal cord. The main function of connective tissues is to provide structural support to organs. Connective tissues consist of cells and an extracellular matrix.Connective Tissue: Histology disease–associated ILD and granulomatous ILD

Table: Typical features of systemicsclerosisSclerosisA pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.Wilms Tumor (a common cause ofCTDCTDDisorders of Fatty Acid Metabolism–associated ILD),sarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis (most common granulomatous ILD), and IPF (most commonidiopathicIdiopathicDermatomyositis ILD)
IPFSystemicsclerosisSclerosisA pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.Wilms Tumor–associated ILDSarcoidosisSarcoidosisSarcoidosis is a multisystem inflammatory disease that causes noncaseating granulomas. The exact etiology is unknown. Sarcoidosis usually affects the lungs and thoracic lymph nodes, but it can also affect almost every system in the body, including the skin, heart, and eyes, most commonly.Sarcoidosis
SymptomsOlder adult with gradualshortness of breathShortness of breathDyspnea is the subjective sensation of breathing discomfort. Dyspnea is a normal manifestation of heavy physical or psychological exertion, but also may be caused by underlying conditions (both pulmonary and extrapulmonary).Dyspnea anddry coughDry CoughStrongyloidiasisGradualshortness of breathShortness of breathDyspnea is the subjective sensation of breathing discomfort. Dyspnea is a normal manifestation of heavy physical or psychological exertion, but also may be caused by underlying conditions (both pulmonary and extrapulmonary).Dyspnea anddry coughDry CoughStrongyloidiasis,fatigueFatigueThe state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.Fibromyalgia,skinSkinThe skin, also referred to as the integumentary system, is the largest organ of the body. The skin is primarily composed of the epidermis (outer layer) and dermis (deep layer). The epidermis is primarily composed of keratinocytes that undergo rapid turnover, while the dermis contains dense layers of connective tissue.Skin: Structure and Functions tightening, Raynaud’s phenomenon, reflux,dysphagiaDysphagiaDysphagia is the subjective sensation of difficulty swallowing. Symptoms can range from a complete inability to swallow, to the sensation of solids or liquids becoming “stuck.” Dysphagia is classified as either oropharyngeal or esophageal, with esophageal dysphagia having 2 sub-types: functional and mechanical.DysphagiaAsymptomatic or with gradualshortness of breathShortness of breathDyspnea is the subjective sensation of breathing discomfort. Dyspnea is a normal manifestation of heavy physical or psychological exertion, but also may be caused by underlying conditions (both pulmonary and extrapulmonary).Dyspnea and cough,fatigueFatigueThe state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.Fibromyalgia,palpitationsPalpitationsEbstein’s Anomaly, jointpainPainAn unpleasant sensation induced by noxious stimuli which are detected by nerve endings of nociceptive neurons.Pain: Types and Pathways, eye andskinSkinThe skin, also referred to as the integumentary system, is the largest organ of the body. The skin is primarily composed of the epidermis (outer layer) and dermis (deep layer). The epidermis is primarily composed of keratinocytes that undergo rapid turnover, while the dermis contains dense layers of connective tissue.Skin: Structure and Functions involvement
SignsCrackles at lungbasesBasesUsually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines.Acid-Base Balance and digitalclubbingClubbingCardiovascular ExaminationCrackles,skinSkinThe skin, also referred to as the integumentary system, is the largest organ of the body. The skin is primarily composed of the epidermis (outer layer) and dermis (deep layer). The epidermis is primarily composed of keratinocytes that undergo rapid turnover, while the dermis contains dense layers of connective tissue.Skin: Structure and Functions thickening and jointswellingSwellingInflammation,telangiectasiasTelangiectasiasAtaxia-telangiectasiaNone or crackles,skinSkinThe skin, also referred to as the integumentary system, is the largest organ of the body. The skin is primarily composed of the epidermis (outer layer) and dermis (deep layer). The epidermis is primarily composed of keratinocytes that undergo rapid turnover, while the dermis contains dense layers of connective tissue.Skin: Structure and Functions findings, jointswellingSwellingInflammation,lymphadenopathyLymphadenopathyLymphadenopathy is lymph node enlargement (> 1 cm) and is benign and self-limited in most patients. Etiologies include malignancy, infection, and autoimmune disorders, as well as iatrogenic causes such as the use of certain medications. Generalized lymphadenopathy often indicates underlying systemic disease.Lymphadenopathy
ExposuresTobacco smokeMostly unknownMostly unknown
HRCTHRCTPulmonary Function Tests
  • Bilateral peripheral reticular pattern in lower posterior lung zones
  • Honeycombing
  • TractionalbronchiectasisBronchiectasisBronchiectasis is a chronic disease of the airways that results from permanent bronchial distortion. This results from a continuous cycle of inflammation, bronchial damage and dilation, impaired clearance of secretions, and recurrent infections.Bronchiectasis
  • UIP pattern is diagnostic.
UIP or NSIP pattern, dilatedesophagusEsophagusThe esophagus is a muscular tube-shaped organ of around 25 centimeters in length that connects the pharynx to the stomach. The organ extends from approximately the 6th cervical vertebra to the 11th thoracic vertebra and can be divided grossly into 3 parts: the cervical part, the thoracic part, and the abdominal part.Esophagus: Anatomy, pulmonary vascular dilationMediastinal/hilarlymphadenopathyLymphadenopathyLymphadenopathy is lymph node enlargement (> 1 cm) and is benign and self-limited in most patients. Etiologies include malignancy, infection, and autoimmune disorders, as well as iatrogenic causes such as the use of certain medications. Generalized lymphadenopathy often indicates underlying systemic disease.Lymphadenopathy, reticulonodular peribronchiovascular involvement
HistopathologyUIP pattern (fibroblastic foci, honeycombing, spatial heterogeneity)NSIP pattern with occasional UIP featuresNon-caseating granuloma
Clinical course3–5 year survival: 50%10-year survival: 70%–80%Overall good survival
Systemic sclerosis

Computed tomography scans in a patient with systemic sclerosis:
(A) Interstitial lung disease was observed in lower lobes in a 47-year-old patient.
(B) Squamous cell lung cancer occurred in the area of interstitial lung disease in a 50-year-old patient.

Image: “Systemic sclerosis” by Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. License:CC BY 2.0
Chest radiograph showing massive hilar and mediastinal lymphadenopathy

Patient with sarcoidosis: (a). Chest radiograph showing massive hilar and mediastinal lymphadenopathy; (b) thoracic CT scan showing diffuse nodular infiltration of the lung interstitium. Neither of these patients complained of cough.

Image: “Chest radiograph” by College of Medicine, Swansea University, Swansea, Wales, UK. License:CC BY 2.0

Complications

  • Acute exacerbations of IIPs:
    • Accelerated phaseAccelerated phaseThe phase of chronic myeloid leukemia following the chronic phase, where there are increased systemic symptoms, worsening cytopenias, and refractory leukocytosis.Chronic Myeloid Leukemia of lung injury in a patient with an underlying ILD
    • Acute onset (< 30 days) of respiratory distress andhypoxemiaHypoxemiaNeonatal Respiratory Distress Syndrome more severe than what was previously experienced by the underlying ILD and not explained by other causes (e.g.,pneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia,heart failureHeart FailureA heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (ventricular dysfunction), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as myocardial infarction.Total Anomalous Pulmonary Venous Return (TAPVR))
    • Most commonly described in IPF
    • LungHRCTHRCTPulmonary Function Tests shows a change in the pattern previously observed due to the underlying ILD with patchy bilateral ground-glass opacities andconsolidationConsolidationPulmonary Function Tests in dependent regions.
    • Histopathology shows diffuse alveolar damage.
    • Treatment is supportive as no proven therapy exists;lung transplantationLung transplantationThe transference of either one or both of the lungs from one human or animal to another.Organ Transplantation may provide cure.
    • MortalityMortalityAll deaths reported in a given population.Measures of Health Status rate > 85%
  • Pulmonary hypertensionPulmonary HypertensionPulmonary hypertension (PH) or pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary arterial pressure, which can lead to chronic progressive right heart failure. Pulmonary hypertension is grouped into 5 categories based on etiology, which include primary PAH, and PH due to cardiac disease, lung or hypoxic disease, chronic thromboembolic disease, and multifactorial or unclear etiologies.Pulmonary Hypertension
  • PneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia
  • Ischemic heart diseaseIschemic heart diseaseCoronary heart disease (CHD), or ischemic heart disease, describes a situation in which an inadequate supply of blood to the myocardium exists due to a stenosis of the coronary arteries, typically from atherosclerosis.Coronary Heart Disease
  • Thromboembolic disease
  • Lung cancerLung cancerLung cancer is the malignant transformation of lung tissue and the leading cause of cancer-related deaths. The majority of cases are associated with long-term smoking. The disease is generally classified histologically as either small cell lung cancer or non-small cell lung cancer. Symptoms include cough, dyspnea, weight loss, and chest discomfort.Lung Cancer

Differential Diagnosis

  • Cardiovascular disease (e.g.,heart failureHeart FailureA heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (ventricular dysfunction), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as myocardial infarction.Total Anomalous Pulmonary Venous Return (TAPVR))
  • DiffuseinfectionsInfectionsInvasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.Chronic Granulomatous Disease (e.g., pneumocystispneumoniaPneumoniaPneumonia or pulmonary inflammation is an acute or chronic inflammation of lung tissue. Causes include infection with bacteria, viruses, or fungi. In more rare cases, pneumonia can also be caused through toxic triggers through inhalation of toxic substances, immunological processes, or in the course of radiotherapy.Pneumonia)
  • MalignancyMalignancyHemothorax (e.g., bronchoalveolar cell carcinoma):
    • Note that ILDs such as COP may occur secondary todermatomyositisDermatomyositisA subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms.Paraneoplastic Syndromes andmalignancyMalignancyHemothorax; however, lung malignancies such as bronchoalveolar cell carcinoma can mimic the symptoms and signs of ILD.

References

  1. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill Education; 2018.
  2. King TE, Raj R. Role of lung biopsy in the diagnosis of interstitial lung disease, in UpToDate Evidence-Based Medicine. Retrieved on August 18, 2020, fromhttps://www.uptodate.com/contents/role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease?search=interstitial-lung-disease&topicRef=4310&source=see_link#H4256910517

Study with Lecturio for

© 2025 Lecturio GmbH. All rights reserved.

USMLE™ is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). MCAT is a registered trademark of the Association of American Medical Colleges (AAMC). NCLEX®, NCLEX-RN®, and NCLEX-PN® are registered trademarks of the National Council of State Boards of Nursing, Inc (NCSBN®). None of the trademark holders are endorsed by nor affiliated with Lecturio.

Create your free account or log in to continue reading!

Sign up now and get free access to Lecturio with concept pages, medical videos, and questions for your medical education.

User Reviews

Best Week. Best Price. Best Prep! 💸 Get 40% off all plans and certificates now >>

Details
×
Get Premium to test your knowledge

Lecturio Premium gives you full access to all content & features

Get Premium to watch all videos

Verify your email now to get a free trial.

Create a free account to test your knowledge

Lecturio Premium gives you full access to all contents and features—including Lecturio’s Qbank with up-to-date board-style questions.

Get Premium
or log in
0/5 questions correct
Start Test

[8]ページ先頭

©2009-2025 Movatter.jp